Filter
538
Filtered Results: 538
Text search:
Bulgaria
Featured
Recommendations
46
New Publications
99
Language
Document type
No document type
291
Studies & Reports
127
Guidelines
29
Manuals
21
Situation Updates
12
Infographics
12
Brochures
11
Resource Platforms
11
Training Material
9
Fact sheets
9
Strategic & Response Plan
6
Countries / Regions
Western and Central Europe
80
Germany
65
Global
26
Eastern Europe
22
Ukraine
19
Eastern Europe and Central Asia
9
Syria
6
Latin America and the Carribbean
5
North Macedonia
4
Hungary
4
Moldova
4
Romania
4
Poland
4
Turkey
3
Albania
3
Bulgaria
2
Africa
2
Asia
2
Slovakia
2
Greece
2
Tajikistan
1
Nepal
1
Switzerland
1
Rwanda
1
Uzbekistan
1
Afghanistan
1
Guinea
1
Italy
1
USA
1
Venezuela
1
Croatia
1
Lithuania
1
Ireland
1
Middle East and North Africa
1
Belarus
1
Slovenia
1
Bolivia
1
Brazil
1
Russia
1
Ethiopia
1
Liberia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
61
Clinical Guidelines
28
Public Health
22
Women & Child Health
22
Key Resources
20
Capacity Building
14
Pharmacy & Technologies
4
Toolboxes
Refugee
123
Mental Health
88
HIV
55
TB
37
COVID-19
35
Disability
28
Conflict
28
Rapid Response
13
AMR
13
Planetary Health
12
Pharmacy
9
Global Health Education
9
Ebola & Marburg
7
NTDs
6
Health Financing Toolbox
6
Zika
6
Polio
5
Specific Hazards
3
Caregiver
3
Natural Hazards
2
Cholera
1
NCDs
1
Malaria
1
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, surveillance and healt...
Surveillance Report
Runfree 2030
Chinese Medicine, (2016) 11:37
Medicinal plants are globally valuable sources of herbal products, and they are disappearing at a high speed. This article reviews global trends, developments and prospects for the strategies and methodologies concerning the conservation and sustainable use of me...
Medicinal plants are globally valuable sources of herbal products, and they are disappearing at a high speed. This article reviews global trends, developments and prospects for the strategies and methodologies concerning the conservation and sustainable use of me...
OECD Family database www.oecd.org/social/family/database
OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs
Research Paper, Accessed April 10,2019
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply...
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change. ...
Kyiv, Ukraine 22-24 November 2010
Meeting Report
2nd edition. Training module on malaria control
UNAIDS 2019, Reference
This edition of UNAIDS data shows the results of some of those successes, but also the challenges that remain. It contains the very latest data on the world’s response to HIV, consolidating a small part of the huge volume of data collected, analysed and refined by UNAIDS ov...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
Health is routinely considered in strategic environmental assessment (SEA) and environmental impact assessment (EIA), following requirements of European Union directives and the Protocol on Strategic Environmental Assessment to the Convention on Environmental Impact Assessment in a Trans...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
